Advertisements
Huh-7
Price: | US$ depends / Unit |
---|---|
Minimum Order: | |
Payment Terms: | L/C |
Port of Export: |
Product Details
Model No.: | ABC-TC0437 | Brand Name: | AcceGen |
---|
Certification: | |
---|---|
Specification: |
AcceGen provides cryopreserved Huh7 Cell Line for the best viability and plating efficiency. AcceGen Huh7 Cells can be grown in serum-free medium and show a high level of P53 with a constitutive mutation. Key Features -Backed by AcceGen advanced technology -Cryopreserved for highest viability and plating efficiency -Quality-tested for accurate results |
Packaging & Delivery
Packaging: | dry ice |
---|---|
Delivery/Lead Time: | |
Production Capacity: |
Product Description
Huh7 Derivation and culture Huh7 cell line is an immortal tumorigenic cell line, established from a well differentiated hepatocellular carcinoma cell. It is firstly derived from a 57-year-old Japanese in 1982. Huh7 human hepatoma cells are epithelial-like and adherent to the flask surface.
Huh7 characters and applications
Huh7 is hypersensitive to the hepatitis C virus (HCV) so that Huh-7 and its derivatives are commonly used as a hepatoma model for HCV infectious research and related drug development. Their expression of a Y220C-mutated form of p53 is aberrantly stable but transcriptionally inactive.
Huh-7 cells are heterogeneous, as the chromosome number of most Huh7 cells is between 55 and 63 (mode 60).
Huh-7 is metastatic in mice, thus can be injected into immunodeficient mouse to create mouse model, where the growth of Huh-7 cells can be monitored. Such preclinical animal models are crucial to tumor growth inhibition studies.
SUPPLIER PROFILE
|
|||
---|---|---|---|
Company: | AcceGen Biotechnology | ||
City/State | Fairfield, NJ | Country: | United States |
Business Type: | Export - Manufacturer / Trading Company | Established: | 2016 |
Member Since: | 2021 | Contact Person | AcceGen Biotech |
SUPPLIER PROFILE
City/State/Country -
Fairfield, NJ
United States
Business Type -
Export - Manufacturer / Trading Company
Established -
2016
Member Since -
2021
Contact Person -
AcceGen Biotech